(Circulation. 2002;106:836.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
From UCSF Medical Center (J.G.Z.), San Francisco, Calif; University of Pennsylvania (B.R.R.), Philadelphia; University of Michigan (W.F.A.), Ann Arbor; California Transplant Donor Network (W.D.B.), Oakland, Calif; University of Wisconsin (A.D.A.), Madison; Massachusets General Hospital (G.W.D.), Boston; Columbia University (N.M.E.), New York, NY; Medical College of Virginia (R.S.H.), Richmond; University of Chicago (V.J.), Ill; United Network for Organ Sharing (M.K.), Richmond, Va; University of Alabama at Birmingham (J.K.K.); Papworth Hospital (S.R.L., J.W.), Cambridge, UK; University of California (D.M.), Los Angeles; Southwest Transplant Alliance (T.S.P.), Dallas, Tex; University of Texas Southwestern Medical Center (W.S.R.), Dallas; Stanford University (R.C.R.), Stanford, Calif; Duke University (S.D.R.), Durham, NC; Cleveland Clinic Foundation (D.O.T., J.B.Y.), Ohio; Medical University of South Carolina (A.V.B.), Charleston.
Correspondence to Jonathan G. Zaroff, MD, UCSF Medical Center, 505 Parnassus Ave, Moffitt Suite 1176, San Francisco, CA 94143-0124. E-mail zaroff{at}medicine.ucsf.edu
The shortage of available donor hearts continues to limit cardiac transplantation. For this reason, strict criteria have limited the number of patients placed on the US waiting list to
6000 to 8000 per year. Because the number of available donor hearts has not increased beyond
2500 per year, the transplant waiting list mortality rate remains substantial. Suboptimal and variable utilization of donor hearts has compounded the problem in the United States. In 1999, the average donor yield from 55 US regions was 39%, ranging from 19% to 62%. This report provides the detailed cardiac recommendations from the conference on "Maximizing Use of Organs Recovered From the Cadaver Donor" held March 28 to 29, 2001, in Crystal City, Va. The specific objective of the report is to provide recommendations to improve the evaluation and successful utilization of potential cardiac donors. The report describes the accuracy of current techniques such as echocardiography in the assessment of donor heart function before recovery and the impact of these data on donor yield. The rationale for and specific details of a donor-management pathway that uses pulmonary artery catheterization and hormonal resuscitation are provided. Administrative recommendations such as enhanced communication strategies among transplant centers and organ-procurement organizations, financial incentives for organ recovery, and expansion of donor database fields for research are also described.
Key Words: transplantation resuscitation catheterization echocardiography
This article has been cited by other articles:
![]() |
S. Goland, L. S.C. Czer, R. M. Kass, R. J. Siegel, J. Mirocha, M. A. De Robertis, J. Lee, S. Raissi, W. Cheng, G. Fontana, et al. Use of Cardiac Allografts With Mild and Moderate Left Ventricular Hypertrophy Can Be Safely Used in Heart Transplantation to Expand the Donor Pool J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1214 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. U. Nwakanma, A. S. Shah, J. V. Conte, and W. A. Baumgartner Heart Transplantation Card. Surg. Adult, January 1, 2008; 3(2008): 1539 - 1578. [Full Text] |
||||
![]() |
M. J. Semigran, L. W. Stevenson, J. J. Passeri, and J. R. Stone Case 37-2007 -- A 47-Year-Old Man with Left Ventricular Dysfunction after Heart Transplantation N. Engl. J. Med., November 29, 2007; 357(22): 2286 - 2297. [Full Text] [PDF] |
||||
![]() |
L. B. Gasink, E. A. Blumberg, A. R. Localio, S. S. Desai, A. K. Israni, and E. Lautenbach Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients. JAMA, October 18, 2006; 296(15): 1843 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kutsogiannis, G. Pagliarello, C. Doig, H. Ross, and S. D. Shemie Medical management to optimize donor organ potential: review of the literature: [Traitement medical pour optimaliser le potentiel de don d'organe : une revue documentaire]. Can J Anesth, August 1, 2006; 53(8): 820 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Stoica, D. K. Satchithananda, P. A. White, L. Sharples, J. Parameshwar, A. N. Redington, and S. R. Large Brain death leads to abnormal contractile properties of the human donor right ventricle J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 116 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Mauro, G. Di Giammarco, G. Vitolla, M. Contini, A. L. Iaco, A. Bivona, L. Weltert, and A. M. Calafiore Impact of No-to-Moderate Mitral Regurgitation on Late Results After Isolated Coronary Artery Bypass Grafting in Patients With Ischemic Cardiomyopathy Ann. Thorac. Surg., June 1, 2006; 81(6): 2128 - 2134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Shemie, H. Ross, J. Pagliarello, A. J. Baker, P. D. Greig, T. Brand, S. Cockfield, S. Keshavjee, P. Nickerson, V. Rao, et al. Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential. Can. Med. Assoc. J., March 14, 2006; 174(6): S13 - S32. [Full Text] [PDF] |
||||
![]() |
S. D. Shemie, H. Ross, J. Pagliarello, A. J. Baker, P. D. Greig, T. Brand, S. Cockfield, S. Keshavjee, P. Nickerson, V. Rao, et al. La prise en charge des donneurs d'organes au Canada : recommandations du forum Optimiser le maintien du donneur afin d'accroitre le nombre d'organes admissibles pour la transplantation Can. Med. Assoc. J., March 14, 2006; 174(6): SF14 - SF32. [Full Text] [PDF] |
||||
![]() |
S. Ullah, L. Zabala, B. Watkins, and M. L Schmitz Cardiac organ donor management Perfusion, March 1, 2006; 21(2): 93 - 98. [Abstract] [PDF] |
||||
![]() |
T. Caus, F. Kober, A. Mouly-Bandini, A. Riberi, D. R. Metras, P. J. Cozzone, and M. Bernard 31P MRS of heart grafts provides metabolic markers of early dysfunction Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 576 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Navia, F. A. Atik, A. Marullo, R. C. Starling, M. Garcia, P. R. Vega, N. G. Smedira, and P. M. McCarthy Bench Repair of Donor Aortic Valve With Minimal Access Orthotopic Heart Transplantation Ann. Thorac. Surg., July 1, 2005; 80(1): 313 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Jacobs, A. Spital, K. E. Wood, D. Coursin, and A. D'Alessandro Care of the Potential Organ Donor N. Engl. J. Med., March 24, 2005; 352(12): 1266 - 1267. [Full Text] [PDF] |
||||
![]() |
J. Butler, R. Howser, P. M. Portner, and R. N. Pierson III Body Mass Index and Outcomes After Left Ventricular Assist Device Placement Ann. Thorac. Surg., January 1, 2005; 79(1): 66 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Antunes, D. Prieto, L. Eugenio, and M. J. Antunes Donor mitral valve repair in cardiac transplantation J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 227 - 228. [Full Text] [PDF] |
||||
![]() |
S. Taghavi, A. Zuckermann, J. Ankersmit, G. Wieselthaler, A. Rajek, G. Laufer, E. Wolner, and M. Grimm Extracorporeal Membrane Oxygenation is Superior to Right Ventricular Assist Device for Acute Right Ventricular Failure After Heart Transplantation Ann. Thorac. Surg., November 1, 2004; 78(5): 1644 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gupta, V. Piacentino III, M. Macha, A. K. Singhal, J. P. Gaughan, J. B. McClurken, B. I. Goldman, C. A. Fisher, D. Beltramo, J. Monacchio, et al. Effect of older donor age on risk for mortality after heart transplantation Ann. Thorac. Surg., September 1, 2004; 78(3): 890 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Lazar, P. A. Shapiro, B. E. Jaski, M. K. Parides, R. C. Bourge, J. T. Watson, L. Damme, W. Dembitsky, J. D. Hosenpud, L. Gupta, et al. Neurological Events During Long-Term Mechanical Circulatory Support for Heart Failure: The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Experience Circulation, May 25, 2004; 109(20): 2423 - 2427. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Eisen Adverse outcomes from the use of older donor hearts in cardiac transplant recipients: The pros and cons of expanded donor criteria J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1562 - 1564. [Full Text] [PDF] |
||||
![]() |
A. F. L. Schinkel, D. Poldermans, V. Rizzello, J.-L. J. Vanoverschelde, A. Elhendy, E. Boersma, J. R.T.C. Roelandt, and J. J. Bax Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 385 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Eltzschig, R. Ehlers, S. K. Shernan, W. Rodriguez, S. M. Silver, D. Schoevaerdts, C. Swine, D. Vanpee, M. Jessup, and S. Brozena Heart Failure N. Engl. J. Med., September 4, 2003; 349(10): 1002 - 1004. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |